COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.217
https://www.valueinhealthjournal.com/article/S1098-3015(13)02122-0/fulltext
Title : COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02122-0&doi=10.1016/j.jval.2013.08.217
First page : A359
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 204
Categories :
Tags :
Regions :
ViH Article Tags :